Status:
COMPLETED
Wellnara Post-marketing Surveillance in Japan
Lead Sponsor:
Bayer
Conditions:
Osteoporosis, Postmenopausal
Eligibility:
FEMALE
Brief Summary
This study is a regulatory post marketing surveillance in Japan, and it is a local prospective and observational study of patients who have received Wellnara for postmenopausal osteoporosis. The objec...
Eligibility Criteria
Inclusion
- Patients who received Wellnara for postmenopausal osteoporosis
Exclusion
- Patients who are contraindicated based on the product label
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
411 Patients enrolled
Trial Details
Trial ID
NCT01401114
Start Date
March 1 2009
End Date
September 1 2014
Last Update
September 28 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Japan